Diagnostic testing such as gastric emptying scintigraphy should be performed after appropriate washout of GLP-1 receptor agonists per American College of Gastroenterology guidelines
For subcutaneous injections such as retatrutide, the sites used in clinical trials consistent with RCN and NHS guidance for similar agents include: Abdomen: The area at least 5 cm away from the navel is the most commonly used site, offering a relatively large surface area and predictable absorption
People who are pregnant or breastfeeding, those with kidney disease, seizure disorders, or thyroid conditions, and anyone on medications that could interact should avoid it unless a physician specifically approves it
pea-sized amount once daily, usually evening Neck and dcolletage: 2 %3 % nightly
While we focus mainly on analyzing inspection-based warning letters, we also offer general context on all warning letters for these product categories